Evidence map›Paper›PMID 41978101›Full record

ArticleNutrients2026

Energy-Metabolism-Enhancing Probiotics Enhance the Therapeutic Response to a Glucagon-like Peptide-1 Receptor Agonist.

A-Ram Kim, Seong-Gak Jeon, So-Jung Park, Byoung-Kook Kim, Mi-Na Kweon, Myoung Ho Jang, Bo-Gie Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A-Ram KimResearch Institute, GI Longevity Inc., Seongnam 13201, Republic of Korea.ORCID 0000-0001-5237-6905
Seong-Gak JeonResearch Institute, GI Longevity Inc., Seongnam 13201, Republic of Korea.
So-Jung ParkResearch Institute, GI Longevity Inc., Seongnam 13201, Republic of Korea.
Byoung-Kook KimMediogen Inc., Jecheon 27159, Republic of Korea.
Mi-Na KweonMucosal Immunology Laboratory, Department of Convergence Medicine, University of Ulsan College of Medicine/Asan Medical Center, Seoul 05505, Republic of Korea.
Myoung Ho JangWorld Premier International Immunology Frontier Research, Osaka University, Suita 565-0871, Japan.
Bo-Gie YangResearch Institute, GI Longevity Inc., Seongnam 13201, Republic of Korea.ORCID 0000-0002-1538-8488

Funding

Korea Health Industry Development Institute HR18C0012
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Energy MetabolismGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like PeptidesImmunoglobulin Fc FragmentsObesityProbioticsRecombinant Fusion ProteinsAnimalsBlood GlucoseDiet, High-FatDisease Models, AnimalGlucagon-Like Peptide-1 ReceptorMaleMiceMice, Inbred C57BLWeight GainBlood GlucosedulaglutideGlucagon-Like Peptide-1 ReceptorGlucagon-Like Peptide-1 Receptor AgonistsGlucagon-Like PeptidesImmunoglobulin Fc FragmentsRecombinant Fusion Proteinsdulaglutideenergy expenditureGLP-1 receptor agonistLimosilactobacillus fermentum GB102obesityprobioticssuccinic acidweight regain

Identifiers

PMID41978101
PMCPMC13074448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.